Organigram Holdings Inc. EPS Growth (diluted)

EPS Growth (diluted) of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (diluted) growth rates and interactive chart. Year over year growth in diluted earnings per share.


Highlights and Quick Summary

  • EPS Growth (diluted) for the quarter ending February 28, 2022 was 95.66% (a -4.34% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (diluted) decreased by -2.15%
  • Annual EPS Growth (diluted) for 2021 was 33.68% (a -103.22% decrease from previous year)
  • Annual EPS Growth (diluted) for 2020 was -1046.58% (a 633.26% increase from previous year)
  • Annual EPS Growth (diluted) for 2019 was -142.73% (a -158.94% decrease from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (diluted) of Organigram Holdings Inc.

Most recent EPS Growth (diluted)of OGI including historical data for past 10 years.

Interactive Chart of EPS Growth (diluted) of Organigram Holdings Inc.

Organigram Holdings Inc. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 95.66%
2021 100.0% 53.33% 97.76% -667.33% 33.68%
2020 -1200.0% -36.36% -640.0% 0.0% -1046.58%
2019 -106.67% -191.67% 86.49% 0.0% -142.73%
2018 1600.0% 209.09% 242.15%
2017 -1239.47%
2016 108.78%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic